Form 8-K - Current report:
SEC Accession No. 0001104659-25-071769
Filing Date
2025-07-29
Accepted
2025-07-29 16:55:48
Documents
12
Period of Report
2025-07-29
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2522000d1_8k.htm   iXBRL 8-K 26289
  Complete submission text file 0001104659-25-071769.txt   190995

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA anip-20250729.xsd EX-101.SCH 3044
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20250729_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20250729_pre.xml EX-101.PRE 22378
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2522000d1_8k_htm.xml XML 3538
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 251162571
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)